Glanbia Share News (GLB)

UK MORNING BRIEFING: Share Open Lower But Prudential Gains

LONDON (Alliance News) - Share are lower at the open Wednesday, following Asian and US markets.

Just after the open, insurer Prudential declared a 15% dividend increase for 2013. CEO Tidjane Thiam promised "more of the same, just better". It also announced an expand

Glanbia reports improved 2013 results

- Lifts annual profit, strong international nutrition performance - Expects improvement in Dairy Ireland - Predicts earnings growth of 8-10 per cent up to 2018 Nutrition and ingredients company Glanbia posted a healthy increase in annual pre-tax profit underpinned by strong demand at its Global Per

DIRECTOR DEALINGS: Glanbia Non-Executive Sells 2,500 Shares

Glanbia Appoints Mark Garvey As New Group Finance Director

DIRECTOR DEALINGS: Glanbia Non-Executive Director Sells Shares

Glanbia Expects Full-Year Trading In Line With Expectations

Glanbia upbeat despite woes at consumer products unit

Food group Glanbia said it was positive about its full year outlook after a good performance in the first nine months of the year from its two core global businesses offset a challenging time for its Irish consumer products business. The Ireland-based company said it expected to deliver 2013 underl

Dairy Crest Financial Director reduces stake by 3,000

Tom Atherton, the Financial Director of Dairy Crest Group, has sold 2,944 shares, reducing his stake in the company to 3,347. The shares were sold at the average price of 510p over a period of three days. The dairy foods company last month said overall trading in the first quarter was in line wi

Wood Group Chairman sells 250,000 shares

The Chairman of Wood Group has traded in 2.1m pounds-worth of shares in the group. Allister Langlands sold, on behalf of his wife, 250,000 shares 846p each. The deal was announced on the same day the FTSE 100 energy services giant announced its PSN business has scored a contract to deliver oper

Small cap round-up: Angel Biotechnology, Glanbia, MBL Group

Angel Biotechnology has signed an agreement with arGentis Pharmaceuticals that could see it manufacture the firm's ARG201 drug, a treatment for the life-threatening autoimmune disease, systemic sclerosis. Angel's stock rose 6.6% in morning trading. Glanbia, a nutritional solutions and cheese maker,

Boss' s wife splashes out on Standard Life shares

The wife of Standard Life's chief executive has spent nearly £300,000 on a stake in the insurer, the day after the company announced it had a "good" 2010. Caroline Nish, wife of David, bought 125,000 shares at 2,24p a time, taking the couple's stake to about 550,000 shares. The UK's fourth-largest

Glanbia reiterates earnings guidance

Nutritional ingredients and cheese group Glanbia said the group has performed broadly in line with expectations since its interim management statement in November, and reiterated its expectation of an increase of around 20% in adjusted earnings for 2010. Dairy Ireland performed well in the second h

Small caps round-up: Glanbia, LXB Retail, MDM...

Irish ingredients and cheese group Glanbia said it is on track for a very strong performance relative to last year in the first half of 2010. The Irish dairy ingredients business has returned to profitability but the Irish consumer products division has had a tough first half. On the US cheese and

Narrow defeat for Glanbia buy out plan

Glanbia Co-operative Society has failed to secure the required majority of 75% needed to progress the acquisition of the group's Irish Dairy and Agri Businesses. The proposal has been rejected by a narrow margin with 73% of members voting in favour of the deal. John Moloney, Group Managing Directo

London close:Equities advance on broad front

London brought its two day losing streak to an end today, despite a mixed reception to the day's major company announcements and a disappointing set of inflation figures. A sharp rise in fuel costs was responsible for much of the acceleration in the inflation rate, which climbed to 3.4% from 3% in